Home › Funds › F/m Investments LLC › REGN

F/m Investments LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

F/m Investments LLC reported holding 16,167 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 0.36% of its reported portfolio and ranking #48 among its reported holdings. F/m Investments LLC has disclosed REGN holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)16.17K sh
Reported value held$12.26M
Portfolio Weight0.36%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How F/m Investments LLC's REGN position evolved

F/m Investments LLC first disclosed a stake in REGN in Q2 2024 at 6,708 shares (US$7.1M). The position peaked in Q4 2025 at 22,813 shares, worth US$17.6M. Across 10 filings, F/m Investments LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 16,167 shares valued at US$12.3M — a reduction of -616 shares quarter over quarter.. Notable position changes include a 249% increase in Q4 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 6.71K $7.05M New
Q3 2024 6.45K $6.78M Reduce
Q4 2024 7.00K $4.99M Add
Q1 2025 6.60K $4.19M Reduce
Q2 2025 6.69K $3.51M Add
Q3 2025 6.54K $3.68M Reduce
Q4 2025 22.81K $17.61M Add
Q1 2026 17.38K $13.43M Reduce
Q2 2026 16.78K $10.46M Reduce
Q3 2026 16.17K $12.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has F/m Investments LLC held REGN?

F/m Investments LLC has disclosed REGN holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is F/m Investments LLC's current position in REGN?

As of Q3 2026, F/m Investments LLC holds 16.17K shares of REGN (REGENERON PHARMACEUTICALS), valued at $12.26M, representing 0.36% of its reported portfolio and ranking #48.

Has F/m Investments LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), F/m Investments LLC reduced its position in REGN. The position peaked in Q4 2025 at 22.81K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.